Achillon, Cyclacel: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading under $5 were poised to move on above-average volume during Monday's session.

Cyclacel Pharmaceuticals ( CYCC) jumped by 18 cents, or 6%, to $3.18. Cycacel began its surge last week after a lung-cancer drug had successful laboratory tests reported in two industry journals. The 50-day average daily volume for Cyclacel is 3.5 million, according to the Nasdaq.

Achillion Pharmaceuticals ( ACHN) was among the most active pre-market trades, jumping by 46 cents, or 13.5%, to $3.85 in the premarket session on Monday, after the company reported additional positive results for a hepatitis C drug. The 50-day average daily volume for Achillon is 444,000, according to the Nasdaq.

SciClone Pharmaceuticals ( SCLN) spiked 32 cents, or close to 13%, to $2.85 in the premarket session after the biotech firm lifted its sale guidance for 2010 -- a 15% increase. The 50-day average daily volume for SciClone is 320,000, according to the Nasdaq.

Tuesday Morning ( TUES) rose by 71 cents, or 23%, to $3.74 in the premarket session, after the closeout retailer announced higher quarterly earnings and a positive outlook for the next quarter. The 50-day average daily volume for Tuesday Morning is 199,000, according to the Nasdaq.

-- Written by Eric Rosenbaum in New York.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store

Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More from Investing

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Bitcoin Today: Prices Continue to Slump Heading Into Weekend

Bitcoin Today: Prices Continue to Slump Heading Into Weekend

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists